Company Research Report: Mark Cuban Cost Plus Drug Company, PBC

Company Overview

• Name: Mark Cuban Cost Plus Drug Company, PBC

• Mission: The mission of the company is to provide safe, affordable medicines with transparent pricing to improve public health. They aim to eliminate middlemen, drastically reduce drug costs, and introduce transparency in drug pricing for maximum savings to consumers.

• Founded By: The company is co-founded by Mark Cuban and Alexander Oshmyansky.

• Key People:

• Mark Cuban: Co-Founder and Investor

• Alexander Oshmyansky: Co-Founder and CEO

• Headquarters: 320 S. Walton St. Dallas, TX 75226

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: The company is known for offering prescription drugs at significantly lower prices by eliminating traditional middlemen in the pharmaceutical supply chain. They are committed to transparent drug pricing, providing medications at cost plus a 15% markup.

Products

Mark Cuban Cost Plus Drug Company offers a variety of generic medications across different therapeutic areas. Below are some key products:

• Imatinib: Used for treating leukemia. Offered at significantly lower prices compared to the market.

• Fluoxetine: A generic depression drug offered at discounted prices.

• Lisinopril: A generic drug for high blood pressure available at a reduced cost.

High-Level Description

The company focuses on life-saving and common generic medications, providing them at the lowest possible prices directly to consumers, bypassing traditional pharmaceutical distribution channels.

Key Features

• Transparent Pricing: Medications are priced at manufacturing cost plus a 15% markup, offering transparency in drug pricing.

• Wide Range of Medications: Covers areas such as diabetes, heart health, gastrointestinal issues, mental health, high blood pressure, and cancer.

• Online Pharmacy Platform: Easy access for consumers to purchase medications online without the need for traditional pharmacy benefit networks.

• Vertically Integrated Supply Chain: Direct connections with drug manufacturers to secure lower prices.

Recent Developments

Recent Developments in the Company:

• Introduction of Pharmacy Benefit Manager: The company has established a pharmacy benefit manager to bring transparency and reduce costs in the drug supply chain.

• State-of-the-Art Manufacturing Facility: In 2023, the company opened a manufacturing facility in Dallas, Texas to produce high-quality medications, addressing critical needs like drug shortages.

New Products Launched:

• No specific new products were mentioned beyond the current offerings of generic medications.

New Features Added to Existing Products:

• State-of-the-Art Aseptic Robotic Filling Lines: Part of their manufacturing capabilities aimed at producing medications on the FDA's Drug Shortages list at the lowest possible cost.

New Partnerships:

• Wholesale and Pharmacy Services: The company acts as a licensed drug wholesaler nationwide and collaborates with HealthDyne to ensure prescriptions are filled and shipped safely.

Conclusion

Mark Cuban Cost Plus Drug Company is committed to disrupting the pharmaceutical industry by providing affordable medications and transparent pricing. With a strategic approach focusing on eliminating middlemen and launching a manufacturing facility, the company continues to pioneer solutions aimed at reducing drug costs for consumers across the United States.